Dr. Partha Roy Receives R01 Funding to Study Breast Cancer Cells
By Cristina D’Imperio Partha Roy, PhD, McGowan affiliated faculty, [...]
Study Reveals Dual Roles Wielded by Type of Cell Death Involved in Fighting Cancer
The immune system is the body’s army against bacteria, [...]
New Findings on Macrophages in ER+ Breast Cancer
Estrogen receptor-positive (ER+) breast cancer accounts for approximately 70% [...]
Using 3D Modeling to Stop Cancer’s Spread
Most women diagnosed with metastatic ovarian cancer have a [...]
Multi-Center Study Sheds Light on Understudied Breast Cancer Type
A multi-center analysis of patients with invasive lobular carcinoma, [...]
Dr. Partha Roy Lab Member Receives NIH Career Transition Award to Treat Kidney Cancer
David Gau, PhD (pictured top), a lecturer in the [...]
Dr. Kurt Weiss and Pittsburgh Cure Sarcoma
McGowan Institute for Regenerative Medicine affiliated faculty member Kurt [...]
Pitt Spinout Company, Oncorus, Moves Forward
Oncorus, Inc., is a viral immunotherapies company founded in 2016 [...]
Illumination of Immune Checkpoint LAG3 ‘Black Box’ Could Yield New Cancer and Autoimmune Therapies
Fighting cancer and chronic disease is tiring work for the [...]
Welcome: Dr. Hamza Yazdani
The McGowan Institute for Regenerative Medicine welcomes new affiliated faculty [...]